Brokers say these ASX 100 shares are buys right now

These high-quality shares could be just what your portfolio needs.

| More on:
A young investor working on his ASX shares portfolio on his laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While the ASX 100 index may not be as well-known or widely followed as the benchmark ASX 200 index, what it lacks in attention it makes up for in quality.

Among the 100 companies included in the index are some of the biggest and brightest that Australia has to offer. But which ASX 100 shares are buys?

Two that could be worth considering according to analysts are listed below. Here's why they rate these ASX 100 shares as buys:

Cochlear Limited (ASX: COH)

The first ASX 100 share that could be a buy is Cochlear.

It is a leading manufacturer and distributor of cochlear implantable devices for hearing impaired globally. It offers three main products: Cochlear implants, Baha bone conduction implants, and Cochlear Wireless Accessories.

Goldman Sachs believes Cochlear would be a top option for investors right now. Particularly given that trading conditions have improved materially now COVID headwinds are easing. It said:

Looking forward, we continue to express a general preference for the device/drug names over the service providers in the current environment, on the basis of: i) stronger pricing power; ii) more assured volume profiles; iii) more resilient/expanding market shares; and iv) stronger balance sheets.

We believe Cochlear screens well on these fundamental factors, and largely avoids the margin uncertainties prevalent across other verticals. We expect a sequential improvement in momentum through 2H23 (further elective volume improvement and new processor launch momentum, potentially tempered by some moderation in Acoustics). We forecast above guidance in FY23E (GSe: $306m vs. $290-305m) and believe shares will now be further supported by a newly announced multi-year buyback program (GSe: $75m/year).

Its analysts currently have a buy rating and $265.00 price target on its shares.

Seek Ltd (ASX: SEK)

Another ASX 100 share that could be a buy is Seek.

It operates an online employment classifieds platform across 12 countries. It has three main business segments: SEEK Employment, SEEK Learning, and SEEK International.

Morgans is positive on the company. Its analysts believe Seek will benefit from a number of tailwinds that lead to increased reliance on the company's products and services. It explains:

Of the classifieds players, we continue to see SEEK as the one with the most relative upside, a view that's based on the sustained listings growth we've seen over the period. The tailwinds that have driven elevated job ads (~210k currently, broadly flat on the robust pcp) and strong FY22 result appear to still remain in place, i.e. subdued migration, candidate scarcity and the drive for greater employee flexibility. With businesses looking to grow headcount in the coming months and job mobility at historically high levels according to the RBA, we see these favourable operating conditions driving increased reliance on SEEK's products.

Morgans has an add and $28.40 price target on Seek's shares.

Motley Fool contributor James Mickleboro has positions in Seek. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear and Seek. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A colourfully dressed young skydiver wearing heavy gold gloves smiles and gives a thumbs up as he falls through the sky.
Broker Notes

Bell Potter says this ASX silver stock has 'a sky full of upside'

This exciting stock could be a high risk, high reward pick according to the broker.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Broker Notes

These 2 ASX All Ords shares tripled in value last year. Can they keep going?

Both of these ASX shares more than tripled their market capitalisations in 2025.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Morgans says these ASX 200 shares can rise 20%+

The broker says these shares could offer major upside.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Broker Notes

Brokers rate 2 ASX All Ords rippers of 2025: Is their phenomenal run over?

Both of these ASX shares more than tripled in value last year.

Read more »

a woman puts her hand to her chin and looks to the side deep in thought as though pondering something significant.
Broker Notes

2 ASX 200 gold shares to buy and 1 to sell: experts

After exceptional share price growth for 2 years, experts say investors need to choose their gold stocks carefully.

Read more »